product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
SARS-CoV-2 Nucleocapsid MAb (Clone 1035111)
catalog :
MAB10474-100
quantity :
100 ug (also 25 ug)
price :
379 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
1035111
reactivity :
SARS coronavirus
application :
western blot, immunohistochemistry, neutralization
more info or order :
R&D Systems product webpage
citations: 9
Reference
Fujita S, Plianchaisuk A, Deguchi S, Ito H, Nao N, Wang L, et al. Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236. EBioMedicine. 2024;104:105181 pubmed publisher
Madahar V, Dang R, Zhang Q, Liu C, Rodgers V, Liao J. Human Post-Translational SUMOylation Modification of SARS-CoV-2 Nucleocapsid Protein Enhances Its Interaction Affinity with Itself and Plays a Critical Role in Its Nuclear Translocation. Viruses. 2023;15: pubmed publisher
Tamura T, Ito J, Uriu K, Zahradník J, Kida I, Anraku Y, et al. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nat Commun. 2023;14:2800 pubmed publisher
Ito J, Suzuki R, Uriu K, Itakura Y, Zahradník J, Kimura K, et al. Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant. Nat Commun. 2023;14:2671 pubmed publisher
Hany M, Zidan A, Gaballa M, Ibrahim M, Agayby A, Abouelnasr A, et al. Lingering SARS-CoV-2 in Gastric and Gallbladder Tissues of Patients with Previous COVID-19 Infection Undergoing Bariatric Surgery. Obes Surg. 2023;33:139-148 pubmed publisher
Otsubo R, Minamitani T, Kobiyama K, Fujita J, Ito T, Ueno S, et al. Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein. Sci Rep. 2022;12:20120 pubmed publisher
Sulea T, Baardsnes J, Stuible M, Rohani N, Tran A, Parat M, et al. Structure-based dual affinity optimization of a SARS-CoV-1/2 cross-reactive single-domain antibody. PLoS ONE. 2022;17:e0266250 pubmed publisher
Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. 2022;603:700-705 pubmed publisher
Saito A, Irie T, Suzuki R, Maemura T, Nasser H, Uriu K, et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 2022;602:300-306 pubmed publisher
product information
master code :
MAB10474
SKU :
MAB10474-100
product name :
SARS-CoV-2 Nucleocapsid MAb (Clone 1035111)
unit size :
100 ug (also 25 ug)
description :
The SARS-CoV-2 Nucleocapsid MAb (Clone 1035111) from R&D Systems is a mouse monoclonal antibody to Nucleocapsid. This antibody reacts with hamster,hamster - mesocricetus auratus (golden hamster),human,sars-cov-2. The SARS-CoV-2 Nucleocapsid MAb (Clone 1035111) has been validated for the following applications: Immunohistochemistry,Western Blot,Neutralization.
target :
Nucleocapsid
category :
Primary Antibodies
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 ╡m filtered solution in PBS.
clonality :
Monoclonal
clone :
1035111
conjugate :
Unconjugated
host :
Mouse
immunogen :
Spodoptera frugiperda, Sf 21 -derived SARS-CoV-2 Nucleocapsid protein, Met1-Ala419, Accession # YP_009724397.2
isotype :
IgG2b
purity :
Protein A or G purified from hybridoma culture supernatant
species :
Hamster,Hamster - Mesocricetus auratus (Golden Hamster),Human,SARS-CoV-2,Syrian Hamster
specificity :
Detects SARS-CoV-2 Nucleocapsid in direct ELISAs and Western blots. No cross-reactivity with MERS Nucleocapsid is observed in Western blots.
top caption :
Detection of SARS-CoV-2 Nucleocapsid antibody by Western Blot.
accessionNumbers :
YP_009724397.2
applications :
Immunohistochemistry,Western Blot,Neutralization
USD :
379 USD
alt names :
N Protein, Nucleocapsid protein, ORF9a protein
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 6 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
R&D Systems product webpage
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.